Fed. Circ.'s Arduous Legal Landscape For Diagnostic Patents

By Vanessa Yen, Evan Diamond and Julia Kolibachuk (August 20, 2019, 3:53 PM EDT) -- On Aug. 9, 2019, the U.S. Court of Appeals for the Federal Circuit issued a public opinion in Genetic Veterinary Sciences Inc. v. Laboklin GmbH & Co. KG, finding claims directed to methods for detecting a genetic marker for a canine hereditary disease to be patent-ineligible under 35 U.S.C. Section 101.[1]...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!